The TBJ honors have provided significant excitement amongst our entire team. We believe in the company and its mission, and seeing it change the medical research landscape motivates us to work harder to continue to innovate for our clients.
Raleigh, NC (PRWEB) May 16, 2017
Global Specimen Solutions, Inc. (http://www.globalspecimensolutions.com), was selected by the Triangle Business Journal (TBJ) for 2017 Best CRO for the Life Science Awards and Women in Business, Entrepreneur winner for the CEO, Amelia Wall Warner.
“Global Specimen Solutions, Inc. is thrilled to be recognized for the hard work and innovative market solutions developed by our talented team. Our company is growing rapidly and having this recognition is thrilling for all of us.” –Amelia Wall Warner, Founder and CEO
Global Specimen Solutions, Inc. offers innovative services and technology solutions focused on increasing the ability for researchers to make timely, focused, and informed decisions that can improve the quality of clinical trials and medical research. This groundbreaking approach has forged a new market for tracking and managing real time pipeline data for the pharmaceutical industry.
“The TBJ honors have provided significant excitement amongst our entire team. We believe in the company and its mission, and seeing it change the medical research landscape motivates us to work harder to continue to innovate for our clients.” - Amelia Wall Warner, Founder and CEO.
“We are so proud of our CEO, Amelia Warner, for following her idea and founding this women- owned business to aid pharmaceutical companies analyze big data. Our recognition as the CRO of the Triangle for 2017 has brought attention to GSS and to the Triangle from pharmaceutical and biotechnology companies nationwide.“ - Scott Clark, VP, Global QA.
Global Specimen Solutions, Inc. has robust informatics solutions with wraparound services that have been rapidly adopted by the pharmaceutical industry for use during live clinical trials and management of historic data.
“We continue to develop solutions to address key data and operational challenges that our pharmaceutical clients experience during protocol setup, protocol execution, and long-term clinical data interrogation. Our client base is growing and we are excited that our company and CEO are being recognized in the Triangle for these major market achievements”- Tom Wollman, COO
Global Specimen Solutions continues to publish and maintain thought leadership for informed consent, specimen tracking, and assay analytics.
About Global Specimen Solutions, Inc.:
Founded in 2013, Global Specimen Solutions, Inc. is located in Raleigh, NC, where it provides informatics and operational solutions that decrease the time, cost, and risk of human specimen research for the pharmaceutical industry, biotech industry, academia, and other business sectors. The company has built compliant, proprietary processes and tools that rapidly bring capability for precision medicine advancements to its clients.